Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction

European Journal of Clinical Nutrition

Volumn 62, Issue 3, 2008, Pages 411-418

  Aarsetoy H ^a,e   Valente, E ^b   Reine, A ^c   Mansoor, M A ^d   Grundt, H ^a,e   Nilsen, D W T ^a,e  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b Axis Shield Diagnostics Ltd   (United Kingdom)

^c The Hospital of Telemark   (Norway)

^d UNIVERSITY OF AGDER   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; CYANOCOBALAMIN; METHYLMALONIC ACID; TRANSCOBALAMIN; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HEART DEATH; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PROGNOSIS; TIME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MALE; METHYLMALONIC ACID; MYOCARDIAL INFARCTION; ODDS RATIO; PROGNOSIS; RECURRENCE; TIME FACTORS; TRANSCOBALAMINS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 40549101862     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602701     Document Type: Article

References (34)

1. Alpert JS, Thygesen K (2000). The Joint European Society of Cardiology/ American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 21, 1502-1513.
2. Bleie Ø, Refsum H, Ueland PM, Vollset SE, Guttormsen AB, Nexo E et al. (2004). Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B-vitamin intervention. Am J Clin Nutr 80, 641-648.
3. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal Aa, Steigen T et al., for the NORVIT trial investigators (2006). Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354, 1578-1588.
4. Bor MV, Nex E, Hvas AM (2004). Holo-transcobalamin concentration and transcobalamin saturation reflect recent vitamin B12 absorption better than does serum vitamin B12. Clin Chem 50, 1043-1049.
5. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274 1049-1057.
6. Chen X, Remacha AF, Pilar Sardà M, Carmel R (2005). Influence of cobalamin deficiency compared with that of cobalamin absorption on serum holo-transcobalamin II. Am J Clin Nutr 81, 110-114.
7. Clarke R, Frost C, Leroy V, Collins R, for The Homocysteine Lowering Trialists' Collaboration (1998). Lowering blood homocysteine with folic acid based supplements. Meta-analysis of randomised trials. BMJ 316, 894-898.
8. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH et al. (1998). Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms and B vitamins. The Atherosclerosis Risk in Communities (ARIC) study. Circulation 98, 204-210.
9. Franke S, Müller A, Sommer M, Bush M, Kientsch-Engel R, Stein G (2003). Serum level of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation. Clin Nephrol 59, 88-97.
10. Gerhardt W, Waldenstrom J, Hörder M, Hofvendahl S, Billström R, Ljungdahl R et al. (1982). Creatine kinase and creatine kinase B-subunit activity in serum in cases of suspected myocardial infarction. Clin Chem 28, 277-283.
11. Graham IM, O'Challaghan P (2002). Symposium: Vitamin therapy and ischemic heart disease. Cardiovasc Drugs Ther 16, 383-389.
12. Grundt H, Nilsen DWT, Mansoor MA, Hetland Ø, Nordøy A (2003). Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomized double-blind study following an acute myocardial infarction: No effect on endothelial adhesion properties. Pathophysiol Haemost Thromb 33, 88-95.
13. Hankey GJ, Eikelboom JW (1999). Homocysteine and vascular disease. Lancet 354, 407-413.
14. Herrmann W, Obeid R, Schorr H, Geisel J (2003). Functional vitamin B12 deficiency and determination of holotranscobalamin in population at risk. Clin Chem Lab Med 41, 1478-1488.
15. Herrmann W, Obeid R, Schorr H, Geisel J (2005). The usefulness of holotranscobalamin in prediciting vitamin B12 status in different clinical settings. Curr Drug Metab 6, 47-53.
16. Herrmann W, Schorr H, Bodis M, Knapp JP, Müller A, Stein G et al. (2000). Role of homocysteine, cystathionine and methylmalonic acid measurements for diagnosis of vitamin deficiency in high-aged subjects. Eur J Clin Invest 30, 1083-1089.
17. Hetland Ø, Gøransson L, Nilsen DWT (1995). Cardiac troponin-T immunoassay on biotin-streptavidin-coated microplates, preliminary performance in acute myocardial infarction. Scand J Clin Lab Invest 55, 701-713.
18. Hvas A-M, Nexo E (2005). Holotranscobalamin - a first choice assay for diagnosing early vitamin B12 deficiency? J Intern Med 257, 289-298.
19. Lloyd-Wright Z, Hvas A-M, Møller J, Sanders TAB, Nexø E (2003). Holotranscobalamin as an indicator of dietary vitamin B12 deficiency. Clin Chem 49, 2076-2078.
20. Miller JW, Garrod MG, Rockwood AL, Kushnir MM, Allen LH, Haan MN et al. (2006). Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency. Clin Chem 52, 278-285.
21. Moleerergpoom W, Sura T, Sritara P (2004). Association between serum homocysteine, folate and B12 concentration with coronary artery disease in Thai patients. J Med Assoc Thai 87, 674-678.
22. Naurath HJ, Joosten E, Riezler R, Stabler SP, Allen RH, Lindenbaum J (1995). Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 346, 85-89.
23. Nexo E, Christensen A-L, Petersen TE, Fedosov SN (2000). Measurement of transcobalamin by ELISA. Clin Chem 46, 1643-1649.
24. Nexo E, Hvas A-M, Bleie Ø, Refsum H, Fedosov SN, Vollset SE et al. (2002). Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study. Clin Chem 48, 1768-1771.
25. Nilsen DWT, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie L (2001). Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 74, 50-56.
26. Refsum H, Johnston C, Guttormsen AB, Nexo E (2006). Holotranscobalamin and total transcobalamin in human plasma: Determination, determinants and reference values in healthy adults. Clin Chem 52, 129-137.
27. Rifai N, Hagen T, Bradley L, Sakamoto M (1998). Determination of serum physiological concentration of methylmalonic acid by gas chromatography-mass spectrometry with selected ion monitoring. Ann Clin Biochem 35, 633-636.
28. Robinson K, Arheart K, Refsum H, Brattström L, Boers G, Ueland P, et al., for the European COMAC Group (1998). Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 97 437-443.
29. Sundrehagen E (2002) United States Patent 6, 417, 006.
30. Verhaar MC, Stroes E, Rabelink TJ (2002). Folates and cardiovascular disease. Brief reviews. Arterioscler Thromb Vasc Biol 22, 6-13.
31. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP et al. (1996). Homocysteine metabolism and risk of myocardial infarction; relation with vitamins B6, B12 and folate. Am J Epidemiol 143, 845-859.
32. Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT (2001). Low dietary folate intake is associated with an exess incidence of acute coronary events. The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 103, 2674-2680.
33. Wald DS, Law M, Morris JK (2002). Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 325 1202-1207.
34. World Health Organisation (1976). Myocardial infarction community registers. Title: Coopenhagen: World Health Organisation.